Anlotinib Monotherapy in Recurrent or Metastatic Nasopharyngeal Carcinoma: A Multicenter Case-Series Analysis: Anlotinib in NPC. (2025). Radiology and Oncology, 59(4), 617-623. https://www.radioloncol.com/index.php/ro/article/view/4451